Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Devanand Hiralal Dongre, Samarth College of Pharmacy, India.
(2) Devangee P. Shukla, Gujarat University, India.
(3) Adeyemo Isaiah Adeyemi, Olusegun Agagu University of Science and Technology, Nigeria.
(4) Shuja Ur Rehman, Karakoram International University, Pakistan.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 9/10
Average Peer review marks at publication stage: 9.5/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Devanand Hiralal Dongre, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Devangee P. Shukla, India) | File 1 | NA
Stage 2 | Peer Review Report_3 (Adeyemo Isaiah Adeyemi, Nigeria) | File 1 | NA
Stage 2 | Peer Review Report_4 (Shuja Ur Rehman, Pakistan) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA